Albemarle Corporation reported a net loss of $1.1 billion in Q3 2024, compared to a profit of $302.5 million a year ago, as revenue fell 41% to $1.35 billion. The sharp decline was primarily driven by lower lithium carbonate and hydroxide market pricing, though partially offset by higher sales volumes across all segments. Gross margin turned negative at -7.7% compared to 2.4% in Q3 2023.The company recorded $828.1 million in restructuring charges during the quarter, mainly related to stopping construction of Kemerton Train 3 and putting Train 2 into care maintenance in Australia. Management announced a comprehensive cost reduction plan targeting $300-400 million in annual savings, including transitioning to a new functional operating model and reducing global workforce by 6-7% primarily in non-manufacturing roles.Looking ahead, Albemarle expects continued pressure from lower lithium prices but aims to maintain financial flexibility through cost optimization and reduced capital spending. The company amended its credit agreement to modify financial covenants through 2026 given current market conditions. Capital expenditures for 2024 are projected at the lower end of $1.7-1.8 billion range, with plans to cut spending by approximately 50% in 2025.

Albemarle Corporation reported a net loss of $1.1 billion in Q3 2024, compared to a profit of $302.5 million a year ago, as revenue fell 41% to $1.35 billion. The sharp decline was primarily driven by lower lithium carbonate and hydroxide market pricing, though partially offset by higher sales volumes across all segments. Gross margin turned negative at -7.7% compared to 2.4% in Q3 2023.The company recorded $828.1 million in restructuring charges during the quarter, mainly related to stopping construction of Kemerton Train 3 and putting Train 2 into care maintenance in Australia. Management announced a comprehensive cost reduction plan targeting $300-400 million in annual savings, including transitioning to a new functional operating model and reducing global workforce by 6-7% primarily in non-manufacturing roles.Looking ahead, Albemarle expects continued pressure from lower lithium prices but aims to maintain financial flexibility through cost optimization and reduced capital spending. The company amended its credit agreement to modify financial covenants through 2026 given current market conditions. Capital expenditures for 2024 are projected at the lower end of $1.7-1.8 billion range, with plans to cut spending by approximately 50% in 2025.